179 related articles for article (PubMed ID: 1354910)
21. Histamine H2-receptor antagonists.
Keithley JK
Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
[TBL] [Abstract][Full Text] [Related]
22. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
23. [Prevention of stress ulcer with topically active drugs: an effective and sensible therapeutic approach? Arguments pro].
Gugler R
Z Gastroenterol; 1991 Jan; 29 Suppl 1():16-8; discussion 21-2. PubMed ID: 1683733
[No Abstract] [Full Text] [Related]
24. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of ulcer disease].
Loizeau E
Schweiz Med Wochenschr; 1986 Oct; 116(40):1371-4. PubMed ID: 2877491
[TBL] [Abstract][Full Text] [Related]
26. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
27. Practical management of stress-related gastric ulcers.
Holland EG; Taylor AT
J Fam Pract; 1991 Dec; 33(6):625-32. PubMed ID: 1683895
[TBL] [Abstract][Full Text] [Related]
28. Stress ulcer.
Klamut MJ; Keshavarzian A
J Assoc Acad Minor Phys; 1992; 3(3):89-94. PubMed ID: 1498526
[TBL] [Abstract][Full Text] [Related]
29. [Current therapy of ulcer disease].
Hotz J
Wien Med Wochenschr; 1992; 142(8-9):170-9. PubMed ID: 1509768
[TBL] [Abstract][Full Text] [Related]
30. Current guidelines on stress ulcer prophylaxis.
Tryba M; Cook D
Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
[TBL] [Abstract][Full Text] [Related]
31. [Drug therapy of peptic ulcer in the elderly].
Koop H
Z Gerontol; 1992; 25(5):304-8. PubMed ID: 1359717
[TBL] [Abstract][Full Text] [Related]
32. Stress ulceration: a serious complication in critically ill patients.
Konopad E; Noseworthy T
Heart Lung; 1988 Jul; 17(4):339-47. PubMed ID: 3292462
[TBL] [Abstract][Full Text] [Related]
33. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Gostishchev VK; Evseev MA
Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
[TBL] [Abstract][Full Text] [Related]
34. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
[TBL] [Abstract][Full Text] [Related]
35. Peptic ulcer--current status.
Brooks FP
Clin Invest Med; 1987 May; 10(3):108-16. PubMed ID: 3113795
[TBL] [Abstract][Full Text] [Related]
36. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
Sesler JM
AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
[TBL] [Abstract][Full Text] [Related]
37. Indications for the use of parenteral H2-receptor antagonists.
Thompson JC; Walker JP
Am J Med; 1984 Nov; 77(5B):111-5. PubMed ID: 6150638
[TBL] [Abstract][Full Text] [Related]
38. Prevention of NSAID-gastropathy.
Ardizzone S; Bianchi Porro G
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
[TBL] [Abstract][Full Text] [Related]
39. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
Preiser JC
BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
[No Abstract] [Full Text] [Related]
40. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
